This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genentech, Inc.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Po-Wei Yuen: Innovator in Janus Kinase Inhibition
Introduction
Po-Wei Yuen is a prominent inventor based in Ann Arbor, MI, recognized for his contributions to the field of pharmaceutical innovations. He holds a notable patent that has significant implications for the treatment of various diseases through Janus kinase inhibition.
Latest Patents
Yuen's latest patent, titled "5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof," focuses on compounds of Formula (00A) and outlines methods to utilize these compounds as Janus kinase inhibitors. This innovative work has the potential to lead to advancements in therapeutic applications.
Career Highlights
Currently, Po-Wei Yuen is affiliated with Genentech, Inc., a leading biotechnology corporation that focuses on developing medications for serious diseases. His role involves merging scientific research with practical applications in drug development, showcasing his expertise and commitment to innovation in the pharmaceutical industry.
Collaborations
Throughout his career, Yuen has collaborated with distinguished colleagues, including Mark Edward Zak and Nicholas Charles Ray. Together, they harness their collective expertise to drive forward innovative solutions that can make a real difference in healthcare.
Conclusion
Po-Wei Yuen exemplifies the spirit of innovation through his groundbreaking work as a patent holder in the field of Janus kinase inhibitors. His ongoing contributions at Genentech, Inc. not only propel scientific advancements but also highlight the important role of inventors in shaping the future of medicine.